Skip to main content

Advertisement

SpringerLink
Log in

When does early palliative care influence aggressive care at the end of life?

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Background

Early palliative care improves patient quality of life and influences cancer care. The time frame of early has not been established. Eight quality measures reflect aggressive care at the end of life. We retrospectively reviewed patients who died with cancer between January 1, 2018, through December 31, 2019, and compared the timing of palliative care consultation, advance directives (AD), and home palliative care with aggressive care at the end of life (ACEOL).

Methods

Patients without ACEOL indicators were compared to patients with one or more than one indicator of ACEOL. The proportion of patients who received palliative care, completed AD, and the timing of palliative care and AD (less than 30 days, 30–90 days, and greater than 90 days prior to death) was compared for patients who had ACEOL versus those who did not. Chi-square analysis was used for categorical data, one-way ANOVA for continuous variables, and odds ratio (OR) with confidence intervals (CI) was reported as a measure of effect size. A p value ≤ 0.05 was considered significant.

Results

1727 patients died, 46% were female, and the mean age was 69 (SD 11.91). Seventy-one percent had a palliative care consult, 26% completed AD, and 888 (51.4%) had at least one indicator of ACEOL. The most common indicator of ACEOL was new chemotherapy within 30 days of death, in 571 of 888 (64%) of patients experiencing ACEOL. ADs completed at any time reduced ACEOL (OR 0.80, 95%CI 0.64–0.99). Palliative care initiated at 30 days was associated with a greater risk of ACEOL (OR 5.32, 95% CI 3.94–7.18) and initiated between 30 and 90 days (OR 1.39, 95% CI 1.07–1.80) compared to no palliative care but was associated with reduced chemotherapy as an indicator of ACEOL when > 90 days (OR 0.46, 95% CI 0.38–0.57) before death.

Discussion

Completed ADs were associated with reduced chemotherapy in the last 30 days of life and reduced ICU admissions. This may reflect goals of care and end-of-life discussions and transition of care to comfort measures. Palliative care paradoxically when initiated within 90 days before death was associated with greater ACEOL compared to no palliative care. This may be due to consultation late in the course of illness with a focus on crisis management in patients frequently utilizing the health care system. There is an associated reduction in the use of chemotherapy in the last 30 days of life if palliative care is consulted 90 days prior to death.

Conclusions

An initial palliative care consult greater than 90 days before death and ADs completed at any time during the disease trajectory was associated only with reduced chemotherapy in the last 30 days of life compared with no palliative care among the 7 ACEOL indicators. ADs were associated with reduced ICU admissions. Most palliative care consults occurred within 90 days of death and a palliative care consult within 90 days of death is not an optimal utilization of services.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Data availability

NA.

Code availability

NA.

References

  1. Earle CC, Landrum MB, Souza JM, Neville BA, Weeks JC, Ayanian JZ (2008) Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol 26(23):3860–3866

    Article  PubMed  PubMed Central  Google Scholar 

  2. Hui D, Kim SH, Roquemore J, Dev R, Chisholm G, Bruera E (2014) Impact of timing and setting of palliative care referral on quality of end-of-life care in cancer patients. Cancer 120(11):1743–1749

    Article  PubMed  Google Scholar 

  3. Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363(8):733–742

    Article  CAS  PubMed  Google Scholar 

  4. Zimmermann C, Swami N, Krzyzanowska M et al (2014) Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 383(9930):1721–1730

    Article  PubMed  Google Scholar 

  5. Mack JW, Cronin A, Keating NL et al (2012) Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol 30(35):4387–4395

    Article  PubMed  PubMed Central  Google Scholar 

  6. Yoong J, Park ER, Greer JA et al (2013) Early palliative care in advanced lung cancer: a qualitative study. JAMA Intern Med 173(4):283–290

    Article  PubMed  Google Scholar 

  7. Chow E, Abdolell M, Panzarella T et al (2008) Predictive model for survival in patients with advanced cancer. J Clin Oncol 26(36):5863–5869

    Article  PubMed  Google Scholar 

  8. Maltoni M, Scarpi E, Dall’Agata M et al (2016) Systematic versus on-demand early palliative care: results from a multicentre, randomised clinical trial. Eur J Cancer 65:61–68

    Article  PubMed  Google Scholar 

  9. Jang RW, Krzyzanowska MK, Zimmermann C, Taback N, Alibhai SM (2015) Palliative care and the aggressiveness of end-of-life care in patients with advanced pancreatic cancer. J Natl Cancer Inst 107(3):dju424. https://doi.org/10.1093/jnci/dju424

  10. Lees C, Weerasinghe S, Lamond N, Younis T, Ramjeesingh R (2019) Palliative care consultation and aggressive care at end of life in unresectable pancreatic cancer. Curr Oncol 26(1):28–36

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Merchant SJ, Brogly SB, Goldie C et al (2018) Palliative care is associated with reduced aggressive end-of-life care in patients with gastrointestinal cancer. Ann Surg Oncol 25(6):1478–1487

    Article  PubMed  Google Scholar 

  12. Good PD, Cavenagh J, Ravenscroft PJ (2004) Survival after enrollment in an Australian palliative care program. J Pain Symptom Manage 27(4):310–315

    Article  PubMed  Google Scholar 

  13. Bennett MI, Ziegler L, Allsop M, Daniel S, Hurlow A (2016) What determines duration of palliative care before death for patients with advanced disease? A retrospective cohort study of community and hospital palliative care provision in a large UK city. BMJ Open. 6(12):e012576

    Article  PubMed  PubMed Central  Google Scholar 

  14. Lamont EB, Christakis NA (2002) Physician factors in the timing of cancer patient referral to hospice palliative care. Cancer 94(10):2733–2737

    Article  PubMed  Google Scholar 

  15. Jordan RI, Allsop MJ, ElMokhallalati Y et al (2020) Duration of palliative care before death in international routine practice: a systematic review and meta-analysis. BMC Med 18(1):368

    Article  PubMed  PubMed Central  Google Scholar 

  16. Chen CH, Kuo SC, Tang ST (2017) Current status of accurate prognostic awareness in advanced/terminally ill cancer patients: systematic review and meta-regression analysis. Palliat Med 31(5):406–418

    Article  PubMed  Google Scholar 

  17. Tang ST, Wen FH, Hsieh CH et al (2016) Preferences for life-sustaining treatments and associations with accurate prognostic awareness and depressive symptoms in terminally ill cancer patients’ last year of life. J Pain Symptom Manage. 51(1):41-51 e41

    Article  PubMed  Google Scholar 

  18. Liu LN, Chen CH, Liu TW, Lin YC, Lee SC, Tang ST (2015) Preferences for aggressive end-of-life care and their determinants among Taiwanese terminally ill cancer patients. Cancer Nurs 38(3):E9–E18

    Article  PubMed  Google Scholar 

  19. Weeks JC, Catalano PJ, Cronin A et al (2012) Patients’ expectations about effects of chemotherapy for advanced cancer. N Engl J Med 367(17):1616–1625

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Weeks JC, Cook EF, O’Day SJ et al (1998) Relationship between cancer patients’ predictions of prognosis and their treatment preferences. JAMA 279(21):1709–1714

    Article  CAS  PubMed  Google Scholar 

  21. Kao SC, Butow P, Bray V, Clarke SJ, Vardy J (2011) Patient and oncologist estimates of survival in advanced cancer patients. Psychooncology 20(2):213–218

    Article  PubMed  Google Scholar 

  22. Nogler AF (2014) Hoping for the best, preparing for the worst: strategies to promote honesty and prevent medical futility at end-of-life. Dimens Crit Care Nurs 33(1):22–27

    Article  PubMed  Google Scholar 

  23. Emiloju OE, Djibo DAM, Ford JG (2020) Association between the timing of goals-of-care discussion and hospitalization outcomes in patients with metastatic cancer. Am J Hosp Palliat Care 37(6):433–438

    Article  PubMed  Google Scholar 

  24. Lopez-Acevedo M, Havrilesky LJ, Broadwater G et al (2013) Timing of end-of-life care discussion with performance on end-of-life quality indicators in ovarian cancer. Gynecol Oncol 130(1):156–161

    Article  PubMed  Google Scholar 

  25. Mack JW, Cronin A, Taback N et al (2012) End-of-life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med 156(3):204–210

    Article  PubMed  PubMed Central  Google Scholar 

  26. Narang AK, Wright AA, Nicholas LH (2015) Trends in advance care planning in patients with cancer: results from a national longitudinal survey. JAMA Oncol 1(5):601–608

    Article  PubMed  PubMed Central  Google Scholar 

  27. Lund S, Richardson A, May C (2015) Barriers to advance care planning at the end of life: an explanatory systematic review of implementation studies. PLoS One. 10(2):e0116629

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  28. (1995) A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT) The SUPPORT Principal Investigators. JAMA 274(20):1591–1598

  29. Zaros MC, Curtis JR, Silveira MJ, Elmore JG (2013) Opportunity lost: end-of-life discussions in cancer patients who die in the hospital. J Hosp Med 8(6):334–340

    Article  PubMed  Google Scholar 

  30. Marcia L, Ashman ZW, Pillado EB, Kim DY, Plurad DS (2018) Advance directive and do-not-resuscitate status among advanced cancer patients with acute care surgical consultation. Am Surg 84(10):1565–1569

    Article  PubMed  Google Scholar 

  31. Abedini NC, Hechtman RK, Singh AD et al (2019) Interventions to reduce aggressive care at end of life among patients with cancer: a systematic review. Lancet Oncol 20(11):e627–e636

    Article  PubMed  Google Scholar 

  32. Schneiter MK, Karlekar MB, Crispens MA, Prescott LS, Brown AJ (2019) The earlier the better: the role of palliative care consultation on aggressive end of life care, hospice utilization, and advance care planning documentation among gynecologic oncology patients. Support Care Cancer 27(5):1927–1934

    Article  PubMed  Google Scholar 

  33. Wright AA, Keating NL, Ayanian JZ et al (2016) Family perspectives on aggressive cancer care near the end of life. JAMA 315(3):284–292

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Santini D, Zeppola T, Russano M et al (2021) PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort. J Transl Med 19(1):270

    Article  PubMed  PubMed Central  Google Scholar 

  35. Bercow AS, Nitecki R, Haber H et al (2021) Palliative care referral patterns and measures of aggressive care at the end of life in patients with cervical cancer. Int J Gynecol Cancer 31(1):66–72

    Article  PubMed  Google Scholar 

  36. Michael N, Beale G, O’Callaghan C et al (2019) Timing of palliative care referral and aggressive cancer care toward the end-of-life in pancreatic cancer: a retrospective, single-center observational study. BMC Palliat Care 18(1):13

    Article  PubMed  PubMed Central  Google Scholar 

  37. Bhulani N, Gupta A, Gao A et al (2018) Palliative care and end-of-life health care utilization in elderly patients with pancreatic cancer. J Gastrointest Oncol 9(3):495–502

    Article  PubMed  PubMed Central  Google Scholar 

  38. Roeland EJ, Triplett DP, Matsuno RK et al (2016) Patterns of palliative care consultation among elderly patients with cancer. J Natl Compr Canc Netw 14(4):439–445

    Article  CAS  PubMed  Google Scholar 

  39. Siderow S, Silvers A, Meier DE (2016) Palliative care improves quality of care, lowers costs. Manag Care 25(7):40–41

    PubMed  Google Scholar 

  40. Osta BE, Palmer JL, Paraskevopoulos T et al (2008) Interval between first palliative care consult and death in patients diagnosed with advanced cancer at a comprehensive cancer center. J Palliat Med 11(1):51–57

    Article  PubMed  Google Scholar 

  41. Mayer DK, Travers D, Wyss A, Leak A, Waller A (2011) Why do patients with cancer visit emergency departments? Results of a 2008 population study in North Carolina. J Clin Oncol 29(19):2683–2688

    Article  PubMed  PubMed Central  Google Scholar 

  42. Ferrell BR, Temel JS, Temin S et al (2017) Integration of palliative care into standard oncology care: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol 35(1):96–112

    Article  PubMed  Google Scholar 

  43. El-Jawahri A, Greer JA, Temel JS (2011) Does palliative care improve outcomes for patients with incurable illness? A review of the evidence. J Support Oncol 9(3):87–94

    Article  PubMed  Google Scholar 

  44. Qureshi D, Tanuseputro P, Perez R, Pond GR, Seow HY (2019) Early initiation of palliative care is associated with reduced late-life acute-hospital use: a population-based retrospective cohort study. Palliat Med 33(2):150–159

    Article  PubMed  Google Scholar 

  45. Maltoni M, Scarpi E, Dall’Agata M et al (2016) Systematic versus on-demand early palliative care: a randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life. Eur J Cancer 69:110–118

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Geisinger Health System, 100 N. Academy Ave, Danville, PA, 17822, USA

    Mellar P. Davis, Erin A. Vanenkevort, Alexander Elder, Amanda Young, Irina D. Correa Ordonez, Mark J. Wojtowicz, Halle Ellison, Carlos Fernandez, Zankhana Mehta, Bertrand Behm, Glen Digwood & Rajiv Panikkar

Authors
  1. Mellar P. Davis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Erin A. Vanenkevort
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexander Elder
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Amanda Young
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Irina D. Correa Ordonez
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mark J. Wojtowicz
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Halle Ellison
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Carlos Fernandez
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Zankhana Mehta
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Bertrand Behm
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Glen Digwood
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Rajiv Panikkar
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Manuscript development and writing; Mellar Davis, Erin A. Vanenkevort, Alexander Elder, Amanda Young, Irina D. Correa Ordonez, Mark J Wojtowicz, Halle Ellison, Carlos Fernandez, Zankhana Mehta, Bertrand Behm, Glen Digwood, Rajiv Panikkar.

Corresponding author

Correspondence to Mellar P. Davis.

Ethics declarations

Ethics approval

NA.

Consent to participate

NA.

Consent for publication

NA.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Davis, M.P., Vanenkevort, E.A., Elder, A. et al. When does early palliative care influence aggressive care at the end of life?. Support Care Cancer 30, 5371–5379 (2022). https://doi.org/10.1007/s00520-022-06954-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-022-06954-2

Keywords

Search

Navigation